Loading
Lung cancer oncologist who has pushed for universal biomarker testing and better trial design.
Nathan A. Pennell is Vice Chair of Clinical Research at the Taussig Cancer Institute and a member of the Lung Cancer Medical Oncology Program at Cleveland Clinic. He is a lung cancer oncologist known for pushing for universal biomarker testing in non-small-cell lung cancer and for better trial design, and he is an ASCO educational leader on molecular testing. His selected paper addresses the real-world issues and tough choices in biomarker testing for advanced non-small-cell lung cancer. He now leads lung cancer clinical research and research operations at Cleveland Clinic.
| Title | Journal | Year |
|---|---|---|
| Biomarker testing for patients with advanced non-small cell lung cancer: real-world issues and tough choices | ASCO Educational Book | 2019 |